Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.
Bahl & Gaynor Income Growth C AFYCX
- NAV / 1-Day Return 26.36 / +0.11 %
- Total Assets 1.9 Bil
-
Adj. Expense Ratio
- Expense Ratio 1.790%
- Distribution Fee Level Above Average
- Share Class Type Level Load
- Category Large Blend
- Investment Style Large Blend
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 0.80%
- Turnover 12%
USD | NAV as of Sep 26, 2024 | 1-Day Return as of Sep 26, 2024, 10:13 PM GMT+0
Morningstar’s Analysis AFYCX
Will AFYCX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 40.9
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Broadcom Inc | 6.97 | 128.7 Mil | Technology |
Eli Lilly and Co | 5.83 | 107.5 Mil | Healthcare |
Merck & Co Inc | 4.42 | 81.7 Mil | Healthcare |
AbbVie Inc | 4.25 | 78.4 Mil | Healthcare |
PepsiCo Inc | 3.61 | 66.7 Mil | Consumer Defensive |
Procter & Gamble Co | 3.40 | 62.8 Mil | Consumer Defensive |
Mondelez International Inc Class A | 3.23 | 59.7 Mil | Consumer Defensive |
Eaton Corp PLC | 3.17 | 58.6 Mil | Industrials |
NextEra Energy Inc | 3.00 | 55.4 Mil | Utilities |
Chevron Corp | 2.98 | 55.0 Mil | Energy |